Eric Kohlmann

Eric Kohlmann has a long and varied work experience. Eric began their career in 2013 as Co-Founder and Board Member of Kohlmann & Co AG, where they invested in numerous technology startups. In the same year, they also became Co-Founder and Advisor of Bloom Diagnostics, a smart diagnostics startup currently in FDA approval process. In 2016, Eric joined Trinnacle Fund Ltd. as a Board of Directors and SQream as an Investor. In 2018, they became an Investor in CTRL-labs, and in 2020 they joined Arc Ventures as a Venture Partner, partnering with a single family office to manage venture capital portfolio and allocations in over 50 VC Funds. Additionally, they are an Investor in Omneky and in 2022 they will become a Board Member and Investor of Sania Therapeutics and Co-Founder and Board Member of Creatives Care (Non-Profit).

Eric Kohlmann completed a Master's Degree in Finance from IE Business School from 2014 to 2015. From 2010 to 2012, they obtained a Bachelor of Science (BSc) in Physics from ETH Zürich/ TU Munich. Eric also studied Physics at ETH Zürich from 2008 to 2011. From 2006 to 2008, they completed an A-Level in Physics (A), Chemistry (A), Design&Technology (A), German (A), Maths (A), and Further Maths (A) at Eton College.